INSIGHTS ON DRUG DEVELOPMENT

• Color Consistency In UHMWPE Medical Textiles

  Color consistency improves surgical visibility, differentiation, and workflow efficiency, requiring medical textiles that deliver strength, compliance, and reliable quality in every color.

• Transformative Innovation: Advancing Drug Development Using In Silico Modeling

  Explore how predictive modeling and in silico strategies can turn complex data into actionable insights that accelerate drug development and reduce risk across the development lifecycle.

• CDMOs - Key Collaborators In Streamlining Drug Development

  Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.

• Selecting A CDMO For Custom Activated PEGs

  Custom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.

• How Lipid Nanoparticles Enable Next-Gen Delivery

  10/20/2025

  Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.

• Addressing Raw Material Handling Challenges By Dry Granulation

  8/12/2025

  Handling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. Discover how dry granulation improves efficiency, safety, and process reliability.

• Patented Process For Intermediates Useful For Etrasimod Arginine

  3/13/2026

  Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.

• Characterizing Quality Attributes Of GLP-1 Analogs By Light Scattering

  7/31/2025

  Explore how light scattering reveals the structural integrity, aggregation, and stability of GLP-1 analogs to advance drug formulation and enhance treatment efficacy for type 2 diabetes and obesity.

• Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS

  7/29/2025

  Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.